• Product NameQNZ46
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityQNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC50 values are 3, 6, 229, and >300, >300 _mu_M for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively).
• Target NameNMDAR antagonist
• CAS No. 1237744-13-6
• Calculated MW 443.41
• Formulation C24H17N3O6
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:COC1=CC2=C(C=C1)N=C(N(C2=O)C3=CC=C(C=C3)C(=O)O)/C=C/C4=CC(=CC=C4)[N+](=O)[O-]
  Pathways:Neuroscience
  Receptor:NR2A; NR2C; NR2D
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Hansen KB, et al. J Neurosci. 2011 Mar 9;31(10):3650-3661.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting